|
|
|
| First Name: | Matthew | | Last Name: | During | | Title: | Director of Research | | Advanced Degrees: | M.D., D.Sc. | | Affiliation: | Weill Medical College of Cornell University | | Department: | Neurosurgery | | Street Address 1: | 525 East 68th Street | | Street Address 2: | Box 99 | | City: | New York | | State/Province: | NY | | Zip/Postal Code: | 10021 | Country/Territory: | U.S.A. | | Phone: | 212-746-3040 | | Fax: | 212-746-8226 | | Email Address: |  |
Disclosure:
(view policy)
|
Member reports the following financial or other potential conflicts of interest: [Last Modified: 2 August 2004]
I am a founder and consultant for Neurologix, Inc, a biotechnology company which is developing and commercializing gene therapy products for the treatment of neurological disorders
|
|
|
View all comments by Matthew During
|
Neurodevelopmental Disorders (Down syndrome, etc.), Neuromuscular Disorders (ALS, etc.), Polyglutamine Disorders (Huntington's, etc.), Prion Diseases, Stroke and Trauma, Tauopathies, Parkinson Disease, Aging Process, Alzheimer Disease
|
Electrophysiology, Stem cells, Epidemiology, Tau/Cytoskeleton, Genetics, A-beta PP/A-beta, Animal Models, Apoptosis/Cell cycle, Bioinformatics/Statistics, Brain imaging, Chemistry/Pharmacology, Neurotransmission, Clinical trials, Oxidative Stress, Diagnosis, Protein structure/chemistry, DNA microarrays, Proteomics, Drug screening, Signal transduction, Microscopy, Molecular and Cell biology, Neurobiology, Neuroimmunology, Neuropathology
|
|
|
Home
